Average Co-Inventor Count = 12.02
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Compugen Ltd. Corporation (18 from 60 patents)
18 patents:
1. 11795209 - PVRIG polypeptides and methods of treatment
2. 10550173 - PVRIG polypeptides and methods of treatment
3. 10098934 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
4. 9555087 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
5. 9409987 - Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
6. 9375466 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
7. 9347952 - Soluble VEGFR-1 variants for diagnosis of preeclampsia
8. 9107862 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
9. 8415455 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
10. 7906635 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
11. 7842459 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
12. 7714100 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
13. 7667001 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
14. 7569662 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
15. 7553948 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer